Brooklyn, NY, United States of America

Peiming Chen

USPTO Granted Patents = 2 

 


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • New York, NY (US) (2019)
  • Brooklyn, NY (US) (2021)

Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Peiming Chen: Innovator in Nerve Tissue Imaging

Introduction

Peiming Chen is a notable inventor based in Brooklyn, NY, who has made significant contributions to the field of nerve tissue imaging. With a total of two patents to his name, Chen's work focuses on enhancing the understanding and visualization of nerve tissues during surgical procedures.

Latest Patents

Chen's latest patents include groundbreaking innovations such as cyclic peptides with enhanced nerve-binding selectively and nanoparticles bound with these cyclic peptides. These inventions are designed for real-time in vivo nerve tissue imaging. The patents describe methods for using cyclic peptides and nanoparticles bound with cyclic peptides for intraoperative nerve tissue imaging, which can greatly improve surgical outcomes.

Career Highlights

Throughout his career, Peiming Chen has worked with prestigious institutions, including Memorial Sloan Kettering Cancer Center and Cornell University. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Some of Chen's notable coworkers include Michelle S. Bradbury and Barney Yoo, who have collaborated with him on various projects related to nerve tissue imaging.

Conclusion

Peiming Chen's contributions to the field of nerve tissue imaging through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical imaging techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…